Sonova (OTCMKTS:SONVY) Stock Rating Cut to “Hold” at UBS Group

UBS Group lowered shares of Sonova (OTCMKTS:SONVY) from a strong-buy rating to a hold rating in a research note released on Monday,Zacks reports.

Several other equities analysts have also weighed in on SONVY. Citigroup reissued a “sell” rating on shares of Sonova in a research report on Friday, July 24th. The Goldman Sachs Group upgraded shares of Sonova from a “hold” rating to a “buy” rating in a research note on Thursday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold”.

Sonova Trading Down 1.1%

Shares of Sonova stock opened at $68.42 on Monday. The business has a fifty day simple moving average of $61.51 and a two-hundred day simple moving average of $53.34. Sonova has a 1 year low of $42.26 and a 1 year high of $69.66. The company has a quick ratio of 1.43, a current ratio of 1.75 and a debt-to-equity ratio of 0.51.

About Sonova

Sonova Holding AG is a Switzerland-based hearing-care company that develops, manufactures and distributes solutions for people with hearing loss. Its portfolio includes hearing aids, cochlear implants, hearing implants, wireless communication products and related accessories and services.

The company markets products under several brands, including Phonak, Unitron and Advanced Bionics. Sonova also operates hearing-care businesses and retail networks that provide hearing assessments, device fitting, rehabilitation support and after-sales services.